Eulerpool Terminal
The edge that pays for itself.
Current InnoCare Pharma forecasts and price targets in August 2026
Ø Analyst Price Targets
39.54 CNY
+23.86 %
Median
35.70 CNY
+11.84 %
Max
49.64 CNY
Min
34.34 CNY
Last Price
31.92 CNY
Buy
6
Hold
2
Sell
0
The average target price for InnoCare Pharma is 39.54 CNY. (+23.86 % above the current price)
The median price target of InnoCare Pharma is 35.70 CNY.
Stock analysts from many renowned investment banks are closely examining the InnoCare Pharma stock. They conclude their professional InnoCare Pharma stock analyses with a clear recommendation for the InnoCare Pharma stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 6 | 2 | 0 | 39.54 CNY |
| 2026-01-01 | 7 | 2 | 0 | 39.54 CNY |
| 2025-12-01 | 7 | 2 | 0 | 39.54 CNY |
| 2025-12-01 | 7 | 2 | 0 | 39.54 CNY |
| 2025-11-01 | 7 | 2 | 0 | 33.56 CNY |
| 2025-11-01 | 7 | 2 | 0 | 33.56 CNY |
InnoCare Pharma Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for InnoCare Pharma in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2025e | 1.77 B CNY | 101.00 M CNY | 0.06 CNY |
| 2026e | 2.16 B CNY | 129.00 M CNY | 0.08 CNY |
| 2027e | 2.70 B CNY | 444.00 M CNY | 0.26 CNY |